MDM2 SNP309 Accelerates colorectal tumour formation in women
作者： G. L Bond , C. Menin , R. Bertorelle , P. Alhopuro , L. A Aaltonen
关键词:
摘要: Recent studies have shown that the G-allele of MDM2 SNP309 (T/G) in p53 tumour suppressor pathway can accelerate tumorigenesis and alter risk various cancers women not men. In this report, data are presented from two independent groups patients suggest accelerates colorectal formation only women, lend further support to model primarily female-specific hormones, such as oestrogen, could either directly or indirectly allow for women.
elsevier.com
sci-hub.se 参考文章(10)
Helge Lind, Shanbeh Zienolddiny, Per Olav Ekstrøm, Vidar Skaug, Aage Haugen, Association of a functional polymorphism in the promoter of theMDM2 gene with risk of nonsmall cell lung cancer International Journal of Cancer. ,vol. 119, pp. 718- 721 ,(2006) , 10.1002/IJC.21872
Magali Olivier, Ros Eeles, Monica Hollstein, Mohammed A. Khan, Curtis C. Harris, Pierre Hainaut, The IARC TP53 database: new online mutation analysis and recommendations to users. Human Mutation. ,vol. 19, pp. 607- 614 ,(2002) , 10.1002/HUMU.10081
Chiara Menin, Maria Chiara Scaini, Gian Luca De Salvo, Martina Biscuola, Monica Quaggio, Giovanni Esposito, Claudio Belluco, Marco Montagna, Simona Agata, Emma D'Andrea, Donato Nitti, Alberto Amadori, Roberta Bertorelle, Association Between MDM2–SNP309 and Age at Colorectal Cancer Diagnosis According to p53 Mutation Status Journal of the National Cancer Institute. ,vol. 98, pp. 285- 288 ,(2006) , 10.1093/JNCI/DJJ054
Pia Alhopuro, SK Ylisaukko-Oja, WJ Koskinen, Petri Bono, Johanna Arola, Heikki J Järvinen, Jukka-Pekka Mecklin, Timo Atula, Risto Kontio, AA Mäkitie, Sinikka Suominen, Ilmo Leivo, Pia Vahteristo, Leena-Maija Aaltonen, Lauri A Aaltonen, The MDM2 promoter polymorphism SNP309T→G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck Journal of Medical Genetics. ,vol. 42, pp. 694- 698 ,(2005) , 10.1136/JMG.2005.031260
S. Lain, D. Lane, Improving cancer therapy by non-genotoxic activation of p53 European Journal of Cancer. ,vol. 39, pp. 1053- 1060 ,(2003) , 10.1016/S0959-8049(03)00063-7
Gareth Bond, Wenwei Hu, Arnold Levine, MDM2 is a Central Node in the p53 Pathway: 12 Years and Counting Current Cancer Drug Targets. ,vol. 5, pp. 3- 8 ,(2005) , 10.2174/1568009053332627
S Krüger, A Bier, C Engel, E Mangold, C Pagenstecher, M von Knebel Doeberitz, E Holinski-Feder, G Moeslein, K Schulmann, J Plaschke, J Rüschoff, HK Schackert, The p53 codon 72 variation is associated with the age of onset of hereditary non-polyposis colorectal cancer (HNPCC) Journal of Medical Genetics. ,vol. 42, pp. 769- 773 ,(2005) , 10.1136/JMG.2004.028506
Gareth L. Bond, Kim M. Hirshfield, Tomas Kirchhoff, Gabriella Alexe, Elisabeth E. Bond, Harlan Robins, Frank Bartel, Helge Taubert, Peter Wuerl, William Hait, Deborah Toppmeyer, Kenneth Offit, Arnold J. Levine, MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner Cancer Research. ,vol. 66, pp. 5104- 5110 ,(2006) , 10.1158/0008-5472.CAN-06-0180
Gareth L. Bond, Wenwei Hu, Elisabeth E. Bond, Harlan Robins, Stuart G. Lutzker, Nicoleta C. Arva, Jill Bargonetti, Frank Bartel, Helge Taubert, Peter Wuerl, Kenan Onel, Linwah Yip, Shih-Jen Hwang, Louise C. Strong, Guillermina Lozano, Arnold J. Levine, A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell. ,vol. 119, pp. 591- 602 ,(2004) , 10.1016/J.CELL.2004.11.022
J. Shawn Jones, Xuedong Chi, Xiangjun Gu, Patrick M. Lynch, Christopher I. Amos, Marsha L. Frazier, p53 Polymorphism and Age of Onset of Hereditary Nonpolyposis Colorectal Cancer in a Caucasian Population Clinical Cancer Research. ,vol. 10, pp. 5845- 5849 ,(2004) , 10.1158/1078-0432.CCR-03-0590